Insuman Comb 30

Insulin human, the active ingredient in Insuman Comb 30, is an insulin presented as a premixed formulation for subcutaneous use. It treats hyperglycemia in type 1 and type 2 diabetes mellitus by providing both basal and prandial insulin coverage.

GNH USA supplies Insuman Comb 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Comb 30 is an insulin product used to manage blood glucose in diabetes mellitus and related insulin‑deficiency conditions.

- Type 1 diabetes mellitus: provides basal and mealtime insulin to achieve glycemic control. - Type 2 diabetes mellitus: adds exogenous insulin when oral agents are insufficient. - Insulin‑deficiency states: replaces missing endogenous insulin to maintain normal glucose metabolism.

Insuman Comb 30 may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hypoglycemia: low blood glucose episodes, especially if meals are missed. - Injection‑site reactions: redness, swelling or bruising at the injection site. - Weight gain: increased caloric storage associated with improved glucose utilization. - Lipodystrophy: localized changes in subcutaneous fat. - Edema: mild fluid retention. - Nausea: occasional gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hypoglycemia: neurological impairment requiring immediate treatment. - Allergic reactions: urticaria, angioedema or anaphylaxis. - Insulin antibodies: may alter insulin action or cause resistance. - Hypokalemia: low potassium levels in rare cases. - Lipoatrophy: loss of subcutaneous fat at injection sites.

When using Insuman Comb 30, clinicians and patients should observe several safety measures.

- Dose individualization: adjust based on blood‑glucose monitoring and clinical response. - Hypoglycemia risk: avoid dosing when fasting or if meals are delayed. - Illness management: monitor more frequently during infection or stress. - Renal/hepatic impairment: consider reduced clearance and adjust dose accordingly. - Pregnancy and lactation: safety data are limited; use only if benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 30 can interact with several drug classes, influencing glucose control.

Major Interactions (Avoid): - Sulfonylureas: combined use markedly increases risk of severe hypoglycemia. - Potent β‑adrenergic blockers: may mask typical hypoglycemia symptoms such as tachycardia.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: can raise blood glucose, requiring dose adjustment. - Systemic corticosteroids: may increase insulin requirements. - ACE inhibitors: may potentiate hypoglycemic episodes, especially in the elderly.